⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

May 29, 2024American Journal of Roentgenology

Minor (≤ 10%) Ground-Glass Opacity Component in Clinical Stage I Non–Small Cell Lung Cancer: Associations With Pathologic Characteristics and Clinical Outcomes

Meiling Li Jingyi Wang Xiao Bao Fang Wang Fei Zhou Nan Song Ziwei Wan Wěi Li Lei Zhang

View Full Paper

Ask AI

Bookmark

Share

Abstract

Background: The presence of a ground-glass opacity (GGO) component is a favorable prognostic factor in non-small cell lung cancer (NSCLC), although the prognostic impact of a very small GGO component remains poorly investigated.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Li et al. (2024) studied this question.

synapsesocial.com/papers/68e67cc7b6db643587606f9f https://doi.org/10.2214/ajr.24.31283

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Clinicopathological Features and Prognosis of Lung Adenocarcinoma Presenting as Ground-Glass Opacity: A Single-Center Experience2025
2Resected lung adenocarcinoma with lymph node metastasis: is ground glass opacity component a prognostic factor?2024 · 2 citations
3Ground-glass Opacity NodulesPrognostic Study · 2011 · 164 citations
4Ground-glass opacity component as a protective factor for patients with invasive adenocarcinoma ≤3 cm with micropapillary or solid pathological patterns2025 · 5 citations
5Progression of Focal Pure Ground-Glass Opacity Detected by Low-Dose Helical Computed Tomography Screening for Lung CancerRetrospective Study · 2004 · 165 citations